In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study

Safiya Richardson1,2, Jordan Gitlin2, Zachary Kozel2

  • 1Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.

Insights

Obesity is a significant risk factor for mortality in young adults hospitalized with COVID-19. This study identified obesity and comorbidity scores as key predictors of 30-day survival in this demographic.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Young adults (18-39 years) are increasingly hospitalized with COVID-19.
  • Understanding risk factors for severe outcomes in this population is crucial.

Purpose of the Study:

  • To characterize young adults hospitalized with COVID-19.
  • To identify predictors of 30-day in-hospital mortality in this age group.

Main Methods:

  • Retrospective cohort study of 1013 patients aged 18-39 hospitalized with COVID-19.
  • Data extracted from electronic health records across 12 NYC acute care hospitals.
  • Analysis focused on demographic, clinical data, and 30-day survival outcomes.

Main Results:

  • The majority of patients (92.8%) survived hospitalization.
  • Obesity (51.2%) was the most common comorbidity.
  • Obesity (aHR, 2.71) and Charlson comorbidity index (aHR, 1.20) independently predicted higher mortality risk.

Conclusions:

  • Obesity is the strongest negative predictor of 30-day survival in young adults with COVID-19.
  • Comorbidity burden also significantly impacts survival outcomes.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
580
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
486
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
469
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
427
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
252
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
542